Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Asian Pacific Region

Lacuna Sicav - Adamant Asia Pacific Health

+ Add to Watchlist

LACUAPH:LX

223.06 EUR 4.18 1.84%

As of 00:59:30 ET on 04/24/2015.

Snapshot for Lacuna Sicav - Adamant Asia Pacific Health (LACUAPH)

Year To Date: +28.32% 3-Month: +17.06% 3-Year: +26.48% 52-Week Range: 141.16 - 227.84
1-Month: +6.18% 1-Year: +57.36% 5-Year: +13.72% Beta vs MSDEWIN: 0.70

Mutual Fund Chart for LACUAPH

No chart data available.
  • LACUAPH:LX 223.06
  • 1M
  • 1Y
Interactive LACUAPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for LACUAPH

Lacuna Sicav-Adamant Asia Pacific Health is an open-end fund incorporated in Luxembourg. The Fund's objective is growth. The Fund invests at least two-thirds in equities and equity-like securities of companies from the Pacific Rim in the healthcare sector.

Inception Date: 03-30-2006 Telephone: +352 45 13 14 500
Managers: -
Web Site: -

Fundamentals for LACUAPH

NAV (on 2015-04-24) 223.06
Assets (M) (on 2015-04-24) 151.48
Fund Leveraged N
Minimum Investment 3,000.00
Minimum Subsequent Investment 100.00

Dividends for LACUAPH

No dividends reported

Fees & Expenses for LACUAPH

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 0.09
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 2.76

Top Fund Holdings for LACUAPH

Filing Date: 12/31/2014
Name Position Value % of Total
Celltrion Inc 165,165 4,783,902 4.090%
Medy-Tox Inc 20,000 4,559,555 3.898%
Glenmark Pharmaceuticals Ltd 443,000 4,477,444 3.828%
Sawai Pharmaceutical Co Ltd 90,000 4,289,508 3.667%
Shanghai Fosun Pharmaceutical 1,500,000 4,260,913 3.643%
Lupin Ltd 218,000 4,029,484 3.445%
Osstem Implant Co Ltd 150,000 3,856,935 3.298%
M3 Inc 270,000 3,752,094 3.208%
CSPC Pharmaceutical Group Ltd 5,300,000 3,577,368 3.059%
Shimadzu Corp 400,000 3,453,394 2.953%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil